Although DDT has been less studied than MIF in melanoma progression, studies investigating the efficacy of dual MIF and DDT inhibition in bladder cancer models have demonstrated greater antitumor effectiveness compared to either inhibitor alone, suggesting that targeting both MIF and DDT might yield superior clinical outcomes [32]. This evidence concerns the gene MIF and melanoma.